Lymphoma develops when white blood cells called lymphocytes acquire genetic damage that causes them to grow uncontrollably instead of dying on schedule. There isn’t one single cause. Most cases result from a combination of factors: random genetic errors, immune system problems, viral infections, and environmental exposures. Only a small fraction of cases trace back to inherited genes.
What Goes Wrong Inside the Cell
Your immune system constantly produces lymphocytes, a type of white blood cell that fights infections. As part of their normal development, these cells go through a process of rearranging their own DNA to build unique receptors capable of recognizing different threats. This routine DNA shuffling is inherently risky. The enzymes that cut and reassemble genetic segments occasionally make mistakes, producing mutations or misplaced chunks of DNA called translocations.
Most of the time, damaged cells are flagged and destroyed. But if a mutation lands in the right spot, it can flip on growth signals or disable the cell’s built-in self-destruct mechanism. The result is a cell that keeps dividing when it should stop, resists the normal death signals that would clear it out, and eventually crowds out healthy tissue. About 85% of non-Hodgkin lymphomas in Western countries arise from B cells, with the remainder coming from T cells or natural killer cells.
These mutations are almost always acquired during a person’s lifetime rather than inherited at birth. While researchers have found inherited versions of more than a third of the genes known to mutate in one common type of lymphoma (diffuse large B-cell lymphoma), having an inherited variant doesn’t automatically mean you’ll develop the disease. The vast majority of lymphomas are driven by mutations that accumulate over time from the factors described below.
Viral Infections That Raise Risk
Certain viruses can push lymphocytes toward becoming cancerous. The most significant is Epstein-Barr virus (EBV), the virus behind mononucleosis. After the initial infection clears, EBV hides inside B cells for life. In its dormant state, the virus produces proteins that mimic the signals B cells normally need to survive and multiply. One viral protein activates the same growth and survival pathways that a normal immune signal called CD40 would trigger. Another mimics the B cell’s own receptor, keeping the cell alive even when it shouldn’t be.
EBV also produces small molecules called microRNAs that interfere with the cell’s ability to self-destruct, multiply in a controlled way, and be recognized by the immune system. In some lymphomas, EBV causes cells to display a surface protein that essentially tells patrolling immune cells to stand down, letting the cancerous cells escape detection.
Human herpesvirus 8 (HHV-8) is another virus strongly linked to a rare lymphoma called primary effusion lymphoma. Like EBV, it prevents cell death and activates growth-promoting pathways. HIV doesn’t directly cause lymphoma but creates a permissive environment by suppressing the immune system, allowing EBV-infected B cells to proliferate with less oversight. There’s evidence that HIV and EBV cooperate in driving cell growth through shared signaling pathways.
A Weakened Immune System
Anything that significantly suppresses your immune system raises lymphoma risk, because the immune system’s normal job includes surveilling for and eliminating abnormal cells. Organ transplant recipients face some of the highest risks. People who receive heart, lung, or intestinal transplants have an absolute risk of developing a lymphoma-like condition called post-transplant lymphoproliferative disease as high as 25%, largely because of the heavy immunosuppressive drugs needed to prevent organ rejection. Kidney and liver transplant recipients, who need less immunosuppression, face a lower but still elevated risk of 1 to 5%.
The timeline varies. In bone marrow transplant patients, the condition typically appears within 4 to 6 months. In solid organ recipients, EBV-positive cases show up at a median of about 11.5 months, while EBV-negative cases take much longer, around 5 years. The pattern is clear: the more the immune system is suppressed and the longer that suppression lasts, the greater the risk.
Autoimmune Diseases and Chronic Inflammation
Rheumatoid arthritis, lupus, Sjögren’s syndrome, and psoriasis have all been linked to a higher likelihood of developing lymphoma. The connection makes biological sense. In autoimmune diseases, the immune system is chronically activated, forcing B and T cells to divide again and again in response to persistent inflammation. Each round of cell division is another opportunity for a cancer-causing mutation to slip through.
There’s also a molecular link. People with Sjögren’s syndrome, rheumatoid arthritis, and lupus tend to have elevated levels of a protein called B-cell activating factor (BAFF), which is critical for B-cell development. When BAFF levels stay abnormally high, it can drive harmful B-cell activation. Resistance to normal cell death, influenced by proteins like Bcl-2, compounds the problem in conditions like rheumatoid arthritis and lupus. Cells that should die instead persist, accumulating further genetic damage.
Environmental and Chemical Exposures
Benzene, a chemical found in gasoline, industrial solvents, and cigarette smoke, is classified as a carcinogen. While its link to leukemia is well established, a large meta-analysis found that benzene exposure also raises non-Hodgkin lymphoma risk by roughly 23% overall. For people with high occupational exposure, the risk nearly doubles (an 81% increase compared to unexposed individuals). Low and moderate exposure levels showed little meaningful increase, suggesting that dose matters significantly.
Pesticides have also been studied extensively. Agricultural workers with prolonged exposure to certain herbicides and insecticides show elevated lymphoma rates, though pinpointing which specific chemicals are responsible has proven difficult because farm workers are typically exposed to many products over the course of their careers.
Lifestyle Factors
Large pooled studies from the International Lymphoma Epidemiology Consortium have found that cigarette smoking slightly increases the overall risk of non-Hodgkin lymphoma, with a more notable effect on a subtype called follicular lymphoma. Obesity raises the risk of diffuse large B-cell lymphoma specifically. Interestingly, moderate alcohol consumption appears to be associated with a decreased risk of non-Hodgkin lymphoma across most subtypes, though the reasons for this aren’t fully understood.
Hodgkin vs. Non-Hodgkin Lymphoma
These two broad categories differ not just in treatment but in who gets them and why. Hodgkin lymphoma has a distinctive bimodal age pattern, peaking first between ages 15 and 35 and again after age 55. EBV plays a particularly prominent role in Hodgkin lymphoma, and younger patients in developed countries tend to have a different risk profile than older patients.
Non-Hodgkin lymphoma is far more common and encompasses dozens of subtypes, each with its own risk profile. Some subtypes are more strongly tied to autoimmune conditions, others to viral infections, and still others to chemical exposures. The subtypes also vary by geography: B-cell lymphomas dominate in Western countries at about 85% of cases, while T-cell lymphomas are more common in parts of Asia and other regions. This variation points to the role that different environmental exposures, infectious agents, and possibly genetic backgrounds play in shaping which type of lymphoma develops.
Age and Family History
Non-Hodgkin lymphoma risk rises steadily with age, which aligns with the understanding that genetic damage accumulates over a lifetime. Hodgkin lymphoma’s first peak in young adulthood suggests that immune system maturation and viral exposures during adolescence play a role in that disease specifically.
Having a first-degree relative with lymphoma does modestly increase your risk, but lymphoma is not considered a strongly hereditary cancer. The genetic component is more about inheriting subtle variations in immune function or DNA repair capacity that make someone slightly more vulnerable to the acquired mutations that actually drive the disease. For most people who develop lymphoma, there is no family history and no single identifiable cause. It is the accumulation of multiple small hits over time, from immune challenges, environmental exposures, viral infections, and simple biological bad luck, that eventually tips a normal lymphocyte into a malignant one.